August 18, 2018
Article
An Extraordinary Healer essay honoring PROFESSIONALS OF THE GYNECOLOGIC ONCOLOGY UNIT [KAISER PERMANENTE MEDICAL CENTER, LOS ANGELES, CALIFORNIA]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC